Pediatrician Emphasizes Need for AI Trials in Children
Pediatrician Dua Hassan has highlighted the critical necessity for rigorous testing of artificial intelligence (AI) applications developed for children. Hassan advocates for randomized controlled trials that focus on measuring actual developmental outcomes, rather than solely tracking engagement metrics. This perspective underscores a call for evidence-based approaches in integrating AI technology into children's lives.
A pediatrician, Dua Hassan, recently published an opinion piece emphasizing the critical need for robust evaluation of artificial intelligence (AI) technologies intended for children. Hassan argues that current approaches may not adequately assess the long-term impact of these technologies on young users.
According to Hassan, the development and deployment of AI for children should be supported by "randomized controlled trials measuring real developmental outcomes, not engagement metrics." This approach would aim to provide clearer insights into how AI tools affect children's growth and learning. The opinion piece suggests a call for more stringent research standards to ensure that AI applications are genuinely beneficial for pediatric patients.
(Source: STAT News)
